Sasha Bogdanovich

Sasha Bogdanovich, MD, PhD, MBA, currently holds the position of Executive Director of Clinical Development at Capsida Biotherapeutics since August 2025. Prior roles include Senior Director of Clinical Development at Keros Therapeutics, leading Phase 1 and 2 studies on obesity and neuromuscular conditions, and Associate Medical Director at Atara Biotherapeutics, where Sasha oversaw clinical studies on allogenic T-cell therapy for Multiple Sclerosis. Additional experience encompasses positions as a Senior Medical Science Liaison at EMD Serono, Global Medical Science Liaison at IQVIA, and various academic roles at Northwestern University and The University of Chicago. Academic credentials include a PhD from the University of Pennsylvania in Medical Sciences, an MD from Univerzitet u Novom Sadu, an MBA from Fitchburg State University, an MSc in Neuropsychology, and ongoing studies for an MA in Happiness Studies at Centenary University.